Other

Prepaid expenses

Neurocrine Biosciences Prepaid expenses increased by 31.7% to $224.80M in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryLiquidity
SignalContext dependent
VolatilityStable
First reportedQ4 2024
Last reportedQ1 2026May 5, 2026

How to read this metric

Significant fluctuations may indicate changes in the timing of large annual contracts or operational scaling.

Detailed definition

These are payments made in advance for goods or services that will be received or consumed within the next twelve months...

Peer comparison

Standard across all industries; generally represents a small portion of total current assets.

Metric ID: other_prepaid_expense_current

Historical Data

4 periods
 Q4 '24Q3 '25Q4 '25Q1 '26
Value$48.50M$178.10M$170.70M$224.80M
QoQ Change+267.2%-4.2%+31.7%
YoY Change+252.0%
Range$48.50M$224.80M
Avg YoY Growth+252.0%
Median YoY Growth+252.0%

Frequently Asked Questions

What is Neurocrine Biosciences's prepaid expenses?
Neurocrine Biosciences (NBIX) reported prepaid expenses of $224.80M in Q1 2026.
What does prepaid expenses mean?
Payments made in advance for services or goods that the company will receive within a year.